Church & Dwight on Tuesday announced that the Food and Drug Administration has cleared the First Response Gold Digital Pregnancy Test to determine if a woman is pregnant up to six days before her missed period and with more than 99% accuracy from the day of her expected period.
Walgreens Infusion Services on Monday announced that it has been selected as the preferred provider of home administration services for Makena (hydroxyprogesterone caproate injection), the only FDA-approved medication to help reduce the risk of preterm birth for clinically indicated patients.
Procter & Gamble in August launched its Clearblue Advanced Pregnancy Test with Weeks Estimator — the first and only pregnancy test that also provides an estimate of time since ovulation for women testing pregnant.
Swiss Precision Diagnostics recently launched its Clearblue Advanced Pregnancy Test with Weeks Estimator — the first and only pregnancy test that also provides an estimate of time since ovulation for women testing pregnant — into the U.S. marketplace.
Swiss Precision Diagnostics unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here.
Procter & Gamble launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company.
E.p.t, creator of the original home pregnancy test, has partnered with the American Fertility Association to support the vast community of those who are actively trying to conceive during National Infertility Awareness Month this April.
Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.